Lanthanum Carbonate Tablet, Chewable
Product Images NDC 76282-478

4 FDA label images from Exelan Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lanthanum Carbonate (NDC 76282-478). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lanthanum 01)

Figure 1 (Lanthanum 01)
A line graph showing the difference in phosphorus reduction versus placebo for various doses of lanthanum carbonate (225 mg, 675 mg, 1350 mg, 2250 mg). The y-axis represents the difference in phosphorus levels in mg/dL over a specific time period, with data points connected by a downward sloping line and error bars indicating variability at each dose.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Package)

Principal Display Panel (500 mg Tablet Bottle Package)
Packaging label for Lanthanum Carbonate chewable tablets, 500 mg strength. The label indicates two bottles containing 45 chewable tablets each. Manufactured by InvaGen Pharmaceuticals, Inc. and labeled for Exelan Pharmaceuticals, Inc. The label includes warnings to chew or crush tablets completely before swallowing and to take with or immediately after meals, with instructions for pharmacists to dispense the Medication Guide separately.*
FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Package)

Principal Display Panel (750 mg Tablet Bottle Package)
Lanthanum Carbonate chewable tablets 750 mg carton label for oral use. The label shows the product name, strength (750 mg), dosage form (chewable tablets), and package size (6 bottles/15 tablets each). It is manufactured by InvaGen Pharmaceuticals, Inc. under Exelan Pharmaceuticals, Inc. The label includes warnings not to swallow tablets whole and instructions to chew or crush tablets completely before swallowing. The NDC number 76282-477-90 is visible.*
FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Package)

Principal Display Panel (1000 mg Tablet Bottle Package)
Packaging label for Lanthanum Carbonate chewable tablets, 1000 mg, manufactured by Exelan Pharmaceuticals, Inc. The label includes dosing warnings, patient and pharmacist information, and states the package contains 9 bottles of 10 chewable tablets each. The label emphasizes not swallowing tablets whole and taking them with or immediately after meals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.